Scheduled maintenance upgrade on Thursday 18 February 2016 from 10am to 12noon (GMT)
During this time you may experience an intermittent reduction in performance, with the possibility of our publishing platform services being offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.
A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib
Chem. Commun., 2013,49, 9570-9572
Received 19 Jul 2013, Accepted 16 Aug 2013
First published online 19 Aug 2013
| | | | | | More